Pharmacokinetic properties of noscapine

Eur J Clin Pharmacol. 1982;22(6):535-9. doi: 10.1007/BF00609627.


Noscapine was administered to five healthy volunteers in a randomized crossover design, as an intravenous infusion of 66 mg, and as an oral 150 mg dose of either rapidly dissolving tablets or a tablet containing ion exchange resin-bound noscapine. After i.v. administration, the disposition of noscapine was bi-exponential with an elimination half-life of 2.6 h; the total plasma clearance was 22 ml/min/kg and the volume of distribution (Vdarea) was 4.7 l/kg. The absolute oral bioavailability was 30%, with a 3.6-fold interindividual variation. There was no pharmacokinetic evidence to support a prolonged action of the ion exchange resin tablet.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Administration, Oral
  • Adult
  • Biological Availability
  • Female
  • Humans
  • Injections, Intravenous
  • Intestinal Absorption
  • Kinetics
  • Male
  • Noscapine / administration & dosage
  • Noscapine / adverse effects
  • Noscapine / metabolism*
  • Solubility


  • Noscapine